Safety and Efficacy of SX600 Administered by Lumbosacral Transforaminal Epidural Injection for Radicular Pain

PHASE1,PHASE2

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped Due to the impact of COVID-19 and associated enrollment difficulties, the study was terminated with a total sample size of 56 randomized patients

Conditions

Lumbar Radiculopathy

Interventions

DRUG: SX600
DRUG: Placebo

Sponsor

SpineThera Australia PTY LTD